Future Perspectives of Nutrigenomics Foods: Benefits vs. Risks

被引:0
|
作者
Ghosh, Dilip [1 ]
机构
[1] Univ Wollongong, Smart Foods Ctr, Wollongong, NSW 2522, Australia
来源
关键词
Nutrigenomics; Nutrigenetics; Nutrigenomics foods; Functional foods; Nutrition; Consumers; Ethical-legal-social issues; Regulation; Gene-diet interactions; Diet; Omics; FUNCTIONAL FOODS; NUTRITION; HEALTH; GENOMICS;
D O I
暂无
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Nutrigenomics defined as the application of high-throughtput genomics tools in nutrition research is now past its incubation phase. The poorly understood associations of diet and disease prevention in particular will likely be the single most important catalyst to its accelerated and continued growth. Whether the goal of matching foods to individual genotypes to improve the health of those individuals can be attained, and personalised nutrigenomic foods enter the world's food markets, depends on numerous hurdles being overcome : some scientific in nature, some, technical and others related to consumer, market or ethical issues. Public adoption of new technologies is ail important determinant Cor their success. Many of the drivers behind the trend in personalisation of food are now known, particularly ethical, legal, and social issues (ELSI) are the major or drivers. Future development in the field or nutrigenomics undoubtedly will place its seemingly huge potential in better perspective. From the scientific responsibility point of view, one hopes that the new perspectives to be pained and progress to be made in this field will be so managed as to take the public at large on board, if we are to avoid another nutrition education disaster of the genetically modified organism type and dimension.
引用
收藏
页码:31 / 36
页数:6
相关论文
共 50 条
  • [31] Nanotechnology in cosmeceuticals: Benefits vs risks
    Ligade, V. S.
    Sreedhar, D.
    Ajay, M.
    Udupa, N.
    [J]. CURRENT SCIENCE, 2007, 93 (05): : 597 - 597
  • [32] RISKS VS BENEFITS OF ANTIPSYCHOTIC DRUGS
    BALDESSARINI, RJ
    LIPINSKI, JF
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1973, 289 (08): : 427 - 428
  • [33] NEW CHEMICALS - RISKS VS BENEFITS
    CARPENTE.RA
    [J]. CHEMICAL & ENGINEERING NEWS, 1970, 48 (43) : 16 - &
  • [34] Low Vs. High Alcohol: Central Benefits Vs. Detriments
    Yousef Tizabi
    Bruk Getachew
    Clifford L. Ferguson
    Antonei B. Csoka
    Karl M. Thompson
    Alejandra Gomez-Paz
    Jana Ruda-Kucerova
    Robert E. Taylor
    [J]. Neurotoxicity Research, 2018, 34 : 860 - 869
  • [35] Low Vs. High Alcohol: Central Benefits Vs. Detriments
    Tizabi, Yousef
    Getachew, Bruk
    Ferguson, Clifford L.
    Csoka, Antonei B.
    Thompson, Karl M.
    Gomez-Paz, Alejandra
    Ruda-Kucerova, Jana
    Taylor, Robert E.
    [J]. NEUROTOXICITY RESEARCH, 2018, 34 (04) : 860 - 869
  • [37] Hedonists vs. the future
    Didsbury, HF
    [J]. FUTURIST, 1999, 33 (10) : 60 - +
  • [38] INUIT FOODS AND DIET - A PRELIMINARY ASSESSMENT OF BENEFITS AND RISKS
    KINLOCH, D
    KUHNLEIN, H
    MUIR, DCG
    [J]. SCIENCE OF THE TOTAL ENVIRONMENT, 1992, 122 (1-2) : 247 - 278
  • [39] Whole lung irradiation using VMAT - dosimetric and NTCP benefits vs. second cancer risks
    Clarke, P.
    Padmanaban, S.
    Partridge, M.
    Foord, T.
    Cutter, D.
    [J]. RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S411 - S411
  • [40] Graft vs. Systemic Heparinization in Living Donor Liver Transplantation: Risks and Benefits to Recipients and Donors
    Bekki, Yuki
    Ikegami, Toru
    Yoshida, Yoshihiro
    Imai, Daisuke
    Itoh, Shinji
    Harimoto, Norifumi
    Uchiyama, Hideaki
    Yoshizumi, Tomoharu
    Maehara, Yoshihiko
    [J]. TRANSPLANTATION, 2016, 100 : S139 - S140